High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells
- PMID: 24583003
- DOI: 10.1016/j.vaccine.2014.02.016
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells
Abstract
High cell densities in animal cell culture can be obtained by continuous perfusion of fresh culture medium across hollow fiber membranes that retain the cells. Careful selection of the membrane type and cut-off allows to control accumulation of target molecules and removal of low molecular weight compounds. In this report, perfusion with the scalable ATF (alternating tangential filtration, Refine Technology) system was evaluated for two suspension cell lines, the avian cell line AGE1.CR and the human cell line CAP. Both were cultivated in chemically defined media optimized for batch cell growth in a 1L stirred tank bioreactor connected to the smallest ATF unit (ATF2) and infected with cell line-adapted human influenza A virus (A/PR/8/34 (H1N1), typical diameter: 80-100 nm). At concentrations of about 25 million cells/mL three different membrane cut-offs (50 kDa, 0.2 μm and 0.5 μm) were tested and compared to batch cultivations performed at 5 million cells/mL. For medium and large cut-offs no cell-density effect could be observed with cell-specific virus yields of 1428-1708 virions/AGE1.CR cell (infected with moi 0.001) and 1883-4086 virions/CAP cell (moi of 0.025) compared to 1292 virions/AGE1.CR cell and 3883 virions/CAP cell in batch cultures. Even at a concentration of 48 million AGE1.CR cells/mL (cut-off: 0.2 μm) a cell-specific yield of 1266 virions/cell was reached. Only for the small cut-off (50 kDa) used with AGE1.CR cells a decrease in cell-specific yield was measured with 518 virions/cell. Surprisingly, the ratio of infectious to total virions seemed to be increased in ATF compared to batch cultures. AGE1.CR cell-derived virus particles were present in the permeate (0.2 and 0.5 μm cut-off), whereas CAP cell-derived virions were not, suggesting possible differences in morphology, aggregation or membrane properties of the virions released by the two cell lines. To our knowledge, this is the first study that illustrates the potential of ATF-based perfusion of chemically defined media across cell-retaining membranes for production of an influenza A vaccine.
Keywords: Batch versus perfusion culture; Cell-density effect; Cell-specific virus yield; Influenza; Membrane cut-off; Suspension cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.Appl Microbiol Biotechnol. 2020 Jun;104(11):4877-4888. doi: 10.1007/s00253-020-10596-x. Epub 2020 Apr 15. Appl Microbiol Biotechnol. 2020. PMID: 32291490 Free PMC article.
-
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23. Appl Microbiol Biotechnol. 2019. PMID: 30796494 Free PMC article.
-
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.Vaccine. 2019 Nov 8;37(47):7011-7018. doi: 10.1016/j.vaccine.2019.06.005. Epub 2019 Jun 29. Vaccine. 2019. PMID: 31266669
-
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.Appl Microbiol Biotechnol. 2016 Mar;100(5):2121-32. doi: 10.1007/s00253-015-7267-9. Epub 2016 Jan 13. Appl Microbiol Biotechnol. 2016. PMID: 26758296 Free PMC article. Review.
-
Designing cell lines for viral vaccine production: Where do we stand?Biotechnol J. 2015 May;10(5):728-40. doi: 10.1002/biot.201400388. Epub 2015 Apr 22. Biotechnol J. 2015. PMID: 25903999 Review.
Cited by
-
Production of retroviral vectors in continuous high cell density culture.Appl Microbiol Biotechnol. 2023 Oct;107(19):5947-5961. doi: 10.1007/s00253-023-12689-9. Epub 2023 Aug 5. Appl Microbiol Biotechnol. 2023. PMID: 37542575 Free PMC article.
-
From single-cell cloning to high-yield influenza virus production - implementing advanced technologies in vaccine process development.Eng Life Sci. 2024 Feb 18;24(4):2300245. doi: 10.1002/elsc.202300245. eCollection 2024 Apr. Eng Life Sci. 2024. PMID: 38584687 Free PMC article.
-
Perfusion Process Intensification for Lentivirus Production Using a Novel Scale-Down Model.Biotechnol Bioeng. 2025 Feb;122(2):344-360. doi: 10.1002/bit.28880. Epub 2024 Nov 13. Biotechnol Bioeng. 2025. PMID: 39535315 Free PMC article.
-
Perfusion process with tangential flow filtration for oncolytic VSV-GP production.Front Bioeng Biotechnol. 2025 May 30;13:1588293. doi: 10.3389/fbioe.2025.1588293. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40521092 Free PMC article.
-
Production of antiviral "OP7 chimera" defective interfering particles free of infectious virus.Appl Microbiol Biotechnol. 2024 Dec;108(1):97. doi: 10.1007/s00253-023-12959-6. Epub 2024 Jan 13. Appl Microbiol Biotechnol. 2024. PMID: 38229300 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous